MILabs debuts next-generation Adaptive U-CT:

Many Steps ahead in preclinical X-ray CT imaging
The only CT system that will fit your needs – Today, tomorrow and beyond

Just take a look at the basic specifications and you will realize that MILabs Adaptive Diagnostic CT capabilities are steps ahead of other systems in terms of accuracy, speed and workflow. Now add scalability for both small and larger animal imaging, plus upgradability to Molecular CT, and you have an X-ray CT system that will put you far ahead of the second-best option. Read more here…

Technology Update: Unique advantages of state-of-the-art SPECT over PET brings amazing benefits to researchers and practitioners
The “new-found” ability of SPECT to perform tomographic imaging with high spatial and temporal resolution in small animals and humans makes MILabs’ SPECT the best tool for preclinical imaging and targeted clinical applications.

Summary of unique capabilities:
Preclinical U-SPECT: down to 0.15 mm resolution – far superior to PET, dynamic organ & whole-body SPECT, simultaneous multi-tracer SPECT imaging, high-energy theranostic applications, superior quantitation accuracy, no positron range blurring.
Clinical Gyro-free G-SPECT: unmatched 3 mm resolution – 10 fold improvement over conventional rotational SPECT, fast dynamic SPECT capabilities, freeze-motion SPECT, ten-fold dose reduction, far more economical than PET.

University of Alabama at Birmingham selects MILabs Adaptive U-CT to Expand its Pulmonary Research

MILabs will provide an advanced U-CTUHR microCT system to the Cystic Fibrosis Research Center (CFRC) at the University of Alabama at Birmingham (UAB). This state-of the art Adaptive X-ray CT system is predicted to play an important role in advancing research programs centered on novel animal models of cystic fibrosis and COPD developed at UAB by providing superior resolution and unmatched tissue accessibility. Read more here…

Meet us at upcoming conferences
Visit MILabs at the upcoming RSNA, 27 November – 2 December, Chicago, North – Hall B: 8317 in the “Netherlands Presents Pavilion”

G-SPECT is not available for clinical use. Sale for such use depends on local (pre)market approval, including FDA and CE certifications.

Copyright © 2016 MILabs, All rights reserved.

unsubscribe from this list    update subscription preferences